By: Richard L. Smith
Attorney General Matthew J. Platkin and the New Jersey Division of Consumer Affairs announced today that Dr. Marc Watson, a vascular surgeon from Cedar Grove, has agreed to permanently cease his medical and surgical practice in the state.
This decision comes as a resolution to allegations that Dr. Watson indiscriminately prescribed high volumes of controlled dangerous substances (CDS) to patients, particularly those being treated for addiction.
The allegations against Dr. Watson, stemming from an extensive investigation by the Division’s Enforcement Bureau, include gross negligence, professional misconduct, and the lack of medical justification in prescribing highly addictive medications such as benzodiazepines, stimulants, and, in some cases, narcotics.
Furthermore, Watson's practice was criticized for insufficient patient examinations, monitoring, and record-keeping.
An in-depth review of Watson’s patient records and his medical office indicated prolonged prescriptions of CDS without adequately assessing patients' underlying conditions or considering referrals to other specialists, such as psychiatrists.
During a hearing before the Preliminary Evaluation Committee of the Board in August 2023, Watson admitted to a lack of formal training in addiction medicine, not seeing patients in person or conducting urine drug screens for over a year, and often neglecting to obtain prior medical records before prescribing CDS.
Cari Fais, Acting Director of the Division of Consumer Affairs, emphasized the importance of adherence to laws and regulations when prescribing controlled substances, especially to those with substance use disorders.
The actions taken against Dr. Watson aim to prevent any further endangerment to patients and the public through his medical practice.
As per a final consent order filed on February 22, 2024, Dr. Watson is required to close his medical practice within 30 days, during which he must arrange for the transfer of his patients' care.
His New Jersey CDS Registration will also be permanently retired, and he is prohibited from reapplying for it in the future.
Watson is allowed to maintain his medical license solely for conducting on-site testing of construction workers through his mobile Occupational Safety and Health Administration testing company, with strict restrictions against practicing medicine in any other capacity.
This decisive action underscores New Jersey's commitment to combating the opioid epidemic and ensuring that medical professionals uphold the highest standards of care and ethical practice.